In another prospective cohort study based on the Swedish biologics register (ARTIS), TNF inhibitor users did not experience more breast cancer recurrences than TNF inhibitor non-users among patients with RA and a history of breast cancer [37]. This evidence concerns the gene TNF and rheumatoid arthritis.